A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma	Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm	Recruiting	Phase 2	2024-02-07		NCT05678270

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing InnoCare Pharma Tech Co., Ltd.	26

44 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Cancer Hospital of Shandong First Medical University	Jinan	China	11
Anhui Provincial Hospital	Hefei	China	5
Beijing Cancer Hospital	Beijing	China	208
Beijing Hospital	Beijing	China	33
Beijing Youan Hosptital,Capital Medical University	Beijing	China	1
Cancer Hospital, Chinese Academy of Medical Sciences	Beijing	China	41
Changzhou Tumor Hospital	Changzhou	China	1
First Affiliated Hospital of Zhengzhou University.	Zhengzhou	China	1
Foshan First People's Hospital	Foshan	China	4
Fujian Cancer Hospital	Fujian	China	1
Fujian Medical University Union Hospital	Fuzhou	China	107
General Hospital of Ningxia Medical University	Yinchuan	China	17
Harbin Medical University Cancer Hospital	Harbin	China	102
Hebei Medical University Fourth Hospital	Shijiazhuang	China	3
Henan Cancer Hospital	Zhengzhou	China	57
Hubei Cancer Hospital	Wuhan	China	95
Human Provincial People's Hospital	Changsha	China	1
Hunan Cancer Hospital	Changsha	China	123
Jiangxi Cancer Hospital	Nanchang	China	1
Jiangyin Renmin Hospital	Jiangyin	China	1
Jinan Central Hospital	Jinan	China	37
Liaoning Cancer Hospital&Institute	Shenyang	China	2
Mengchao Hepatobiliary Hospital of Fujian Medical University	Fuzhou	China	8
Peking Union Medical College Hospital	Beijing	China	18
Qilu hospital	Jinan	China	7

Clinical trials